AAD 2024The 2024 American Academy of Dermatology (AAD) Annual Meeting is set to take place March 8-12 at the San Diego Convention Center. From equipment and technology, to comprehensive learning with over 300 education sessions, there’s no other networking opportunity quite like the AAD Annual...
◆ 会议时间:2024年3月8日至12日 ◆ 会议地点:美国 圣迭戈(San Diego, Calif.) ◆ 下次会议:2025年美国皮肤病学会年会(AAD2024) ◆ 会议简介: 2024年第82届美国皮肤科学会(AAD)年会将于2024年3月8日至12日在美国加利福尼亚州圣迭戈举行。AAD年会是全球皮肤科领域最大最具影响力的国际盛会,每届年会都会吸引...
Expand your expertise through hundreds of expert-led sessions and make lasting connections with your peers, all in sunny San Diego. The Academy''s Annua. AAD Annual Meeting 2024 is held in San Diego CA, United States, from 3/8/2024 to 3/8/2024 in San
Gooderham M, et al. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with Chronic Hand Eczema: results of the Phase 3 open-label extension DELTA-3 trial. Presented at the 2024 American Academy of Dermatology Annual Meeting; March 8-12 2024; San Diego, C...
1.Gooderham M, et al. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with Chronic Hand Eczema: results of the Phase 3 open-label extension DELTA-3 trial. Presented at the 2024 American Academy of Dermatology Annual Meeting;March 8-12 2024;San Diego, ...
1.Gooderham M, et al. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with Chronic Hand Eczema: results of the Phase 3 open-label extension DELTA-3 trial. Presented at the 2024 American Academy of Dermatology Annual Meeting;March 8-12 2024;San Diego, ...
Gooderham M, et al. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with Chronic Hand Eczema: results of the Phase 3 open-label extension DELTA-3 trial. Presented at the 2024 American Academy of Dermatology Annual Meeting; March 8-12 2024; San Diego, ...
2024 American Academy of Dermatology Annual Meeting; March 8-12 2024; San Diego, CA. Bauer A, et al. Delgocitinib cream reduces itch and pain in adults with moderate to severe chronic hand eczema: pooled analyses of the Phase 3 DELTA-1 and -2 trials. Presented at the 2024 American ...
1.Gooderham M, et al. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with Chronic Hand Eczema: results of the Phase 3 open-label extension DELTA-3 trial. Presented at the 2024 American Academy of Dermatology Annual Meeting;March 8-12 2024;San Diego, ...
AAD Annual Meeting 2024 will be held during Mar 08 - 12, 2024 at the San Diego Convention Center. Users can also find other trade shows or exhibitions related to AAD Annual Meeting 2024 and Manufacturing & Processing Machinery Fair.